Valuation
OZPHOzone Pharmaceuticals
StockMoscow ExchangeРосіяHealth care
7/10
Ratios vs sector
Medians of Health care companies worldwide (too few in the region).
| Metric | OZPH | Sector median | vs median |
|---|---|---|---|
| P/E | — | 28,5 · n=122 | — |
| P/B | — | 3,0 · n=210 | — |
| P/S | — | 3,7 · n=213 | — |
| EV/EBIT | — | 23,8 · n=110 | — |
| Free-cash-flow yield | — | 2,8% · n=199 | — |
| Dividend yield | 2,84% | 0,00% · n=282 | — |
| Return on equity | — | 2,7% · n=207 | — |
| Return on invested capital | — | 3,7% · n=187 | — |
| Gross margin | — | 62,5% · n=160 | — |
| Net debt / EBITDA | — | 1,14 · n=112 | — |
Value factor: 39 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| Instrument | P/E | P/B | EV/EBIT | Free-cash-flow yield | Dividend yield | Smart Score |
|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | 42,6 | 33,6 | — | 1,6% | 0,6% | 6/10 |
| JNJJohnson & Johnson | 29,1 | 7,2 | — | 3,6% | 2,1% | 8/10 |
| ABBVAbbVie | 79,9 | — | 33,5 | 3,6% | 3,0% | 5/10 |
| MRKMerck | 114,6 | 8,7 | — | 4,4% | 2,3% | 8/10 |
| UNHUnitedHealth | 25,1 | 3,4 | 18,6 | 6,7% | 2,3% | 9/10 |
| NVSNovartis AG | 20,0 | 6,1 | 16,9 | 6,3% | 3,2% | 10/10 |
| TMOThermo Fisher Scientific | 35,7 | 4,7 | 35,2 | 2,9% | 0,3% | 8/10 |
| AMGNAmgen | 26,3 | 19,7 | 24,0 | 4,4% | 2,3% | 6/10 |
| GILDGILEAD | — | 16,1 | — | 6,8% | 2,1% | 4/10 |
| ABTAbbott | 28,5 | 3,4 | 26,8 | 4,1% | 3,0% | 5/10 |
ratios computed by AI-Stock Invest from public filings and end-of-day prices
Вийти з контракту тут · Споживачі ЄС: 14 днів на відмову від покупки.